Angina Pectoris of Coronary Heart Disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with angina pectoris within one year after PCI, and patients with angina pectoris symptoms; 2. Those who meet the standard of TCM syndrome differentiation of blood stasis syndrome; 3. The patient aged 18-75 years, and the gender is not limited; 4. The patient gave informed consent, with good compliance, and cooperated with follow-up follow-up and re-examination.
Exclusion criteria
Exclusion criteria: 1. Patients requiring vascular reconstruction, including myocardial infarction, left ventricular insufficiency, multivessel disease and/or massive myocardial ischemia (ischemic area > 10%), left main disease; 2. Patients with chronic refractory angina; 3. Patients with chronic kidney disease combined with severe heart, lung, liver and other vital organ dysfunction; severe primary disease, such as hematopoietic system and/or severe heart, lung, liver and other vital organ dysfunction; 4. Patients with severe uncontrolled hypertension (systolic blood pressure >= 180mmHg or diastolic blood pressure >= 110mmHg); 5. Severe arrhythmias (ventricular tachycardia, ventricular fibrillation, third-degree atrioventricular block, cardiac arrest, severe sinus tachycardia and bradycardia, sick sinus syndrome, reentrant supraventricular tachycardia, arrhythmias leading to hemodynamic changes); 6. Allergic constitution, or those who are allergic to multiple drugs and foods, or those who are known to be allergic to the ingredients of the drug; 7. Patients participating in other clinical trials or taking other proprietary Chinese medicines within one month; 8. Pregnant or lactating women; 9. Patients with mental, psychological and other problems that do not match the completion of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Angina pectoris scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor necrosis factor alpha;Interleukin 6;Total cholesterol;High-sensitivity C-reactive protein;High density lipoprotein;Fasting insulin;Triglycerides;Fasting blood sugar;Blood clotting function;Low-density lipoprotein;Blood viscosity;Thromboelastogram; | — |
Countries
China
Contacts
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine